Laurent Peyrin-Biroulet,
MD, PhD

Dr. Peyrin-Biroulet is a Professor of Gastroenterology. He is a globally respected authority in Crohn’s disease, ulcerative colitis, intestinal fibrosis and treat-to-target strategies, and has authored more than 1200 peer-reviewed publications. Professor Peyrin-Biroulet was the President of the European Crohn’s and Colitis Organization (ECCO) and Scientific Secretary of the International Organization for the Study of IBD (IOIBD), the two leading international organizations in IBD. Between 2015 and 2023, he was the President of the Groupe d’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID), a unique national network of French IBD centers. His work has been instrumental in shaping contemporary clinical endpoints, disease-modification strategies and regulatory frameworks for IBD drug development.

Dr. Laurent Peyrin-Biroulet, commented, “Palisade Bio’s focus on intestinal fibrosis and precision targeting of PDE4 biology addresses a major unmet need in IBD, particularly in fibrostenotic Crohn’s disease where therapeutic options remain limited. I look forward to contributing my experience in disease modification and clinical development to help advance this promising program.”